Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-21

Clinical Trial Update: IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo [Phase 1]

View source ↗

Summary

Phase 1 long-term follow-up study of T1D patients previously treated with IMCY-0098 or placebo completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IMCY-0098

Snippet

Sponsor: Imcyse SA | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2022-01-21